Reports
Reports
Sale
The global scar treatment market value was USD 19.4 billion in 2022, driven by the prevalence of skin conditions, and rising awareness about the availability of scar treatment options across the globe. The market size is anticipated to grow at a CAGR of 10.9% during the forecast period of 2023-2031 to achieve a value of USD 49.1 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global scar treatment market can be segmented based on:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR report looks into the regional scar treatment markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The global scar treatment market is being driven by the increasing demand for scar removal treatment for burn injuries caused by the rising cases of road accidents. The global market is further driven by the introduction of laser therapy that helps in destroying scar tissue. The hospital segment is the largest shareholder in the market because products such as topical creams and gels, laser instruments, and steroid injections are commonly used for scar removal in hospitals. North America is the leading regional market as a result of the high penetration of laser-based products in skin restoration and scar treatment, instant adoption of advanced products, and the growing awareness regarding aesthetic appearance.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global scar treatment market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Scar Type |
|
Breakup by End User |
|
Breakup by Distribution Channels |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Scar Treatment Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Scar Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Scar Epidemiology (2016-2031)
5.3 Europe Scar Epidemiology (2016-2031)
5.4 Asia-Pacific Scar Epidemiology (2016-2031)
5.5 Latin America Scar Epidemiology (2016-2031)
5.6 Middle East & Africa Scar Epidemiology (2016-2031)
6 Global Scar Treatment Market Overview
6.1 Global Scar Treatment Market Historical Value (2016-2022)
6.2 Global Scar Treatment Market Forecast Value (2023-2031)
7 Global Scar Treatment Market Landscape
7.1 Global Scar Treatment Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Global Scar Treatment Product Landscape
7.2.1 Analysis by Product Type
7.2.2 Analysis by End User
7.2.3 Analysis by Distribution Channel
8 Scar Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Scar Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Scar Treatment Market Segmentation
11.1 Global Scar Treatment Market, by Product Type
11.1.1 Market Overview
11.1.2 Topical Products
11.1.2.1 Creams
11.1.2.2 Gels
11.1.2.3 Silicon Sheets
11.1.2.4 Other Topical Products
11.1.3 Laser Products
11.1.3.1 CO2 Laser
11.1.3.2 Pulse-dyed Laser
11.1.3.3 Other Laser Products
11.1.4 Injectables
11.1.5 Others
11.2 Global Scar Treatment Market, by Scar Type
11.2.1 Market Overview
11.2.2 Atrophic Scars
11.2.3 Hypertrophic Scars
11.2.4 Contracture Scars
11.2.5 Stretch Marks
11.2.6 Others
11.3 Global Scar Treatment Market, by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Clinics
11.3.4 Homecare
11.3.5 Specialty Centers
11.3.6 Others
11.4 Global Scar Treatment Market, by Distribution Channels
11.4.1 Market Overview
11.4.2 Hospitals Pharmacies
11.4.3 Retail Pharmacies
11.4.4 Online Pharmacies
11.4.5 Others
11.5 Global Scar Treatment Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Scar Treatment Therapy Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Scar Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Scar Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Scar Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Scar Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Patent Analysis
17.1 Analysis by Type of Patent
17.2 Analysis by Publication year
17.3 Analysis by Issuing Authority
17.4 Analysis by Patent Age
17.5 Analysis by CPC Analysis
17.6 Analysis by Patent Valuation
17.7 Analysis by Key Players
18 Grants Analysis
18.1 Analysis by year
18.2 Analysis by Amount Awarded
18.3 Analysis by Issuing Authority
18.4 Analysis by Grant Application
18.5 Analysis by Funding Institute
18.6 Analysis by NIH Departments
18.7 Analysis by Recipient Organization
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Funding Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Regulatory Framework
22.1 Regulatory Overview
22.1.1 US FDA
22.1.2 EU EMA
22.1.3 INDIA CDSCO
22.1.4 JAPAN PMDA
22.1.5 Others
23 Supplier Landscape
23.1 Smith Nephew
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Merz Pharma
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Lumenis
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Perrigo Company plc
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Mölnlycke Health Care AB
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 CCA Industries, Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Newmedical Technology Inc
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Suneva Medical
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Stratpharma AG
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 OLIX PHARMACEUTICALS, INC.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Geomedics Pharma
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Vicore Pharma
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
23.13 Nidus Pharma Pvt. Ltd.
23.13.1 Financial Analysis
23.13.2 Product Portfolio
23.13.3 Demographic Reach and Achievements
23.13.4 Mergers and Acquisitions
23.13.5 Certifications
23.14 Sientra, Inc.
23.14.1 Financial Analysis
23.14.2 Product Portfolio
23.14.3 Demographic Reach and Achievements
23.14.4 Mergers and Acquisitions
23.14.5 Certifications
23.15 RXi Pharmaceuticals
23.15.1 Financial Analysis
23.15.2 Product Portfolio
23.15.3 Demographic Reach and Achievements
23.15.4 Mergers and Acquisitions
23.15.5 Certifications
23.16 Johnson & Johnson Services, Inc.
23.16.1 Financial Analysis
23.16.2 Product Portfolio
23.16.3 Demographic Reach and Achievements
23.16.4 Mergers and Acquisitions
23.16.5 Certifications
23.17 Novartis AG
23.17.1 Financial Analysis
23.17.2 Product Portfolio
23.17.3 Demographic Reach and Achievements
23.17.4 Mergers and Acquisitions
23.17.5 Certifications
23.18 Sanofi
23.18.1 Financial Analysis
23.18.2 Product Portfolio
23.18.3 Demographic Reach and Achievements
23.18.4 Mergers and Acquisitions
23.18.5 Certifications
23.19 Bausch Health
23.19.1 Financial Analysis
23.19.2 Product Portfolio
23.19.3 Demographic Reach and Achievements
23.19.4 Mergers and Acquisitions
23.19.5 Certifications
23.20 Bayer AG
23.20.1 Financial Analysis
23.20.2 Product Portfolio
23.20.3 Demographic Reach and Achievements
23.20.4 Mergers and Acquisitions
23.20.5 Certifications
24 Global Scar Treatment Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The scar treatment market was valued at USD 19.4 billion in 2022.
The market is expected to grow at a CAGR of 10.9% from 2023 to 2031 to reach a value of USD 49.1 billion by 2031.
The major drivers of the market include the growing concern amongst people regarding their aesthetic appeal, growing introduction of laser therapy, rising adoption of advanced products, and development of advanced healthcare infrastructures.
The increasing demand for scar removal treatment for burn injuries caused by the rising cases of road accidents is the key industry trend propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading scar type segments in the market are atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks, among others.
The significant product types in the industry are topical products, laser product, and injectable product, among others.
The major end users of scar treatment in the market are hospitals/clinics, retail drug stores, and e-commerce stores.
The major players in the industry are Alliance Pharma PLC, Bausch Health Companies Inc. (Solta Medical), Smith & Nephew plc, Laboratoire HRA Pharma SAS, Lumenis Ltd., Sonoma Pharmaceuticals, Inc., Cynosure LLC, Sientra, Inc., Others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.